Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
The objective of this study was to assess the single dose bioequivalence of Roxane's Ropinirole Tablets, 0.25 mg to ReQuip Tablets, 0.25 mg (GlaxoSmithKline) under fasting conditions using a single-dose, randomized, 2-treatment, 2-period, 2-sequence cross-over design.
Inclusion criteria
- Parkinson's disease,Restless leg syndrome